MIT Professor Susumu Tonegawa, renowned molecular biologist and Nobel laureate, dies at 86
Tonegawa made landmark discoveries about how the immune system generates antibody diversity and how the brain forms memories.
Ketogenic diets may increase cancer risk in the small intestine
MIT researchers have found that a ketogenic high-fat, low-carbohydrate diet fuels the growth of intestinal tumors.
Two MIT faculty members named 2026 Pew Biomedical Scholars
Cell biologist Whitney Henry and immunologist Harikesh Wong will receive four years of flexible funding to advance early-career research on ferroptosis and immune decision-making.
Past participants are now the leaders of MIT’s dynaMIT Club
How the program's biggest fans came full circle and took the helm.
A new vaccine adjuvant could make it easier to eradicate polio
The adjuvant can help the injectable polio vaccine induce a strong immune response in the GI tract, which is considered critical to eradicating the virus.
Four from MIT named 2026 Searle Scholars
Computational neuroscientist Sven Dorkenwald and cell biologist Whitney Henry, along with two MIT alumni, are recognized for their exceptional early-career research contributions.
Big strides in cancer detection and treatment from the tiniest technologies
The MIT Marble Center for Cancer Nanomedicine looks back at 10 years of turning big ideas about nanotechnology into transformative advances for cancer patients.
A new approach to cancer vaccination yields more powerful T cells
Using immune-remodeling mRNA molecules, researchers generated T cells that can slow tumor growth and, in some cases, eradicate tumors.
Three from MIT named 2026 Goldwater Scholars
Rising seniors Deeksha Kumaresh, Anna Liu, and Charlotte Myers are honored for their academic achievements.
Implantable islet cells could control diabetes without insulin injections
The cells can survive in the body for at least three months, producing enough insulin to control blood sugar levels, research shows.
Study reveals why some cancer therapies don’t work for all patients
A backup survival pathway can help tumor cells resist certain lung cancer and other drugs. Combining therapies may offer a solution.
3 Questions: Building predictive models to characterize tumor progression
Assistant Professor Matthew Jones is working to decode molecular processes on the genetic, epigenetic, and microenvironment levels to anticipate how and when tumors evolve to resist treatment.
Injectable “satellite livers” could offer an alternative to liver transplantation
The engineered tissue grafts could take on the liver’s function and help thousands of people with liver failure.
MIT-Royalty Pharma Faculty Founder Initiative supports biotech innovators
Offering substantial prize funding alongside workshops, classes, and mentorship, the initiative helps translate early-stage biotech research into venture-ready innovation.
New AI model could cut the costs of developing protein drugs
MIT researchers used a large language model to optimize the genetic sequences of proteins manufactured by yeast, making production more efficient.